News about targeted therapies in non-small-cell lung cancer in 2015 (except immuno-therapy)

Annales de pathologie
Cécile HamardMarie Wislez

Abstract

Recently, developments of therapies that target abnormally activated signaling pathways are increasing for patients with non-small cell lung cancer. EGFR mutations are found in about 10% of lung cancers, especially in adenocarcinoma, women and non-smokers. Three EGFR inhibitors (erlotinib, gefitinib and afatinib) received a European marketing authorization for up to first line treatment of EGFR mutated NSCLC. Effectiveness of EGFR inhibitors is higher than conventional chemotherapy. Third generation EGFR inhibitors (rociletinib, AZD9291) are effective for patients who develop a resistance mutation such as T790M resistance mutation; they obtained temporary authorization for use in France in 2015. The EML4-ALK translocation is found in about 5% of NSCLC and more particularly in adenocarcinoma of young non-smoking patients. Crizotinib is a new therapeutic standard in ALK translocated NSCLC in second line. Ceritinib is a 2nd generation ALK inhibitor which received a European marketing authorization for up to treatment of ALK translocated NSCLC after progression with crizotinib. INCA supports ACSé program evaluating the efficacy of crizotinib in NSCLC amplified for MET or translocated for ROS1 and ACSé program evaluating the efficac...Continue Reading

References

Mar 9, 2005·Cancer Research·Hisayuki ShigematsuAdi F Gazdar
Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Aug 26, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Osamu KawanoYoshitaka Fujii
Oct 5, 2006·Nature Clinical Practice. Oncology·Matthias Drosten, Brigitte M Pützer
Feb 24, 2007·Nature Reviews. Cancer·Sreenath V SharmaDaniel A Haber
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Jun 25, 2010·The New England Journal of Medicine·Makoto MaemondoUNKNOWN North-East Japan Study Group
Jul 10, 2010·Journal of Biomedicine & Biotechnology·Sylwia JancíkMarián Hajdúch
Oct 29, 2010·The New England Journal of Medicine·Eunice L KwakA John Iafrate
Dec 8, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Geoffrey R OxnardVincent A Miller
Jan 21, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria E ArcilaMarc Ladanyi
Jan 22, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·William D TravisDavid Yankelewitz
Mar 25, 2011·Science Translational Medicine·Lecia V SequistJeffrey A Engelman
Jun 7, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jeong-Ok LeeYung-Jue Bang
Aug 10, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio MarchettiFiamma Buttitta
Nov 11, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L V SequistD Dias-Santagata
Jan 13, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yan FengPatrick C Ma
Jan 31, 2012·The Lancet Oncology·Rafael RosellUNKNOWN Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia T
Mar 2, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jennifer M BolandEunhee S Yi
Mar 28, 2013·Cancer Discovery·Alexander DrilonNaiyer Rizvi
Apr 24, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julien MazièresOliver Gautschi
Jun 4, 2013·The New England Journal of Medicine·Alice T ShawPasi A Jänne
Jul 3, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lecia V SequistMartin Schuler
Aug 6, 2013·Critical Reviews in Oncology/hematology·Jacques CadranelMarie Wislez
Apr 29, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Mihaly CserepesBalazs Dome
Jun 26, 2014·The New England Journal of Medicine·Alice T Shaw, Jeffrey A Engelman
Sep 30, 2014·Applied Immunohistochemistry & Molecular Morphology : AIMM·Harold C SullivanCynthia Cohen
Dec 4, 2014·The New England Journal of Medicine·Benjamin J SolomonUNKNOWN PROFILE 1014 Investigators
Dec 20, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Justin F GainorAlice T Shaw
Jan 28, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel B CostaLucio Crinò
Feb 11, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julien MazièresOliver Gautschi
Feb 28, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G R BlumenscheinP A Jänne

❮ Previous
Next ❯

Citations

Aug 5, 2018·Annals of Intensive Care·C BarthUNKNOWN Lung Cancer in Critical Care (LUCCA) Study Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

© 2022 Meta ULC. All rights reserved